Reply to Angeletti Et Al-Efficacy of Combined Rituximab and Daratumumab Treatment in Posttransplant Recurrent Focal Segmental Glomerulosclerosis.

American Journal of Transplantation(2024)

引用 0|浏览14
暂无评分
关键词
FSGS recurrence,kidney transplantation,daratumumab
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要